{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:48:19Z","timestamp":1751435299314,"version":"3.40.5"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>We aimed to summarize the most significant and impactful publications describing the pharmacotherapeutic care of critically ill patients in 2023.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>PubMed\/MEDLINE and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>STUDY SELECTION:<\/jats:title>\n            <jats:p>Randomized controlled trials and prospective studies of adult critically ill patients assessing a pharmacotherapeutic intervention and reporting clinical endpoints published between January 1, 2023, and December 31, 2023, were eligible for inclusion in this article.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA EXTRACTION:<\/jats:title>\n            <jats:p>Articles from a systematic search and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update were included. An a priori defined three-round modified Delphi process was employed to achieve consensus on the most impactful publications based on the following considerations: 1) overall contribution to scientific knowledge and 2) novelty to the literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SYNTHESIS:<\/jats:title>\n            <jats:p>The systematic search and Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update returned a total of 1202 articles, of which 1164 were excluded. The remaining 38 articles underwent a three-round modified Delphi process. In each round, articles were independently scored based on overall contribution to scientific knowledge and novelty to the literature. Included articles are summarized and their impact discussed. Article topics included hydrocortisone for severe community-acquired pneumonia, inhaled amikacin for prevention of ventilator-associated pneumonia, methylene blue for septic shock, restrictive vs. liberal fluid management for sepsis-induced hypotension, andexanet alfa for major bleeding associated with factor Xa inhibitors, and early administration of four-factor prothrombin complex concentrate in patients with trauma at risk for massive transfusion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>This review provides a summary and perspective on the potential impact of the most relevant articles in 2023 describing advances in the pharmacotherapeutic care of critically ill patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000001162","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T13:00:54Z","timestamp":1727960454000},"page":"e1162","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Major Publications in the Critical Care Pharmacotherapy Literature: 2023"],"prefix":"10.1097","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6660-9749","authenticated-orcid":false,"given":"Brian","family":"Murray","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janhavi","family":"Athale","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Mayo Clinic Arizona, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Balk","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Rush Medical College and Rush University Medical Center, Chicago, IL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Behal","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Tennessee Medical Center, Knoxville, TN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judah E.","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, NewYork Presbyterian Hospital\/Columbia University Irving Medical Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"Chanas","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, ECU Health Medical Center, Greenville, NC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Dumitru","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, NewYork Presbyterian Hospital\/Columbia University Irving Medical Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalton C.","family":"Gifford","sequence":"additional","affiliation":[{"name":"Department of Vascular and Interventional Radiology, University of Kentucky, Lexington, KY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Hohlfelder","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Cleveland Clinic, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honey M.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina Medical Center, Chapel Hill, NC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Beth F.","family":"Makic","sequence":"additional","affiliation":[{"name":"University of Colorado Anschutz Medical Campus, College of Nursing, Aurora, CO."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle S.","family":"Rausen","sequence":"additional","affiliation":[{"name":"Department of Respiratory Therapy, Memorial Sloan Kettering Cancer Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia J.","family":"Sacco","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mayo Clinic, Phoenix, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin J.","family":"Sines","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary Diseases and Critical Care Medicine, University of North Carlina at Chapel Hill, Chapel Hill, NC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Payal K.","family":"Gurnani","sequence":"additional","affiliation":[{"name":"Department of Pharmcy, Houston Methodist Hospital, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"R1-20241003","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00134-023-07073-0","article-title":"Publication hyper-inflation in the field of intensive care.","volume":"49","author":"Tsutsumi","year":"2023","journal-title":"Intensive Care Med"},{"key":"R2-20241003","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s13054-023-04666-5","article-title":"Proportions and trends of critical care trials in leading general medical journals, 1970-2022.","volume":"27","author":"Hsu","year":"2023","journal-title":"Crit Care"},{"key":"R3-20241003","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/bmj.331.7525.1129","article-title":"Keeping up: Learning in the workplace.","volume":"331","author":"Wyatt","year":"2005","journal-title":"BMJ"},{"key":"R4-20241003","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4300\/JGME-D-18-00621.1","article-title":"Staying up to date and managing information overload.","volume":"10","author":"Maggio","year":"2018","journal-title":"J Grad Med Educ"},{"key":"R5-20241003","doi-asserted-by":"crossref","first-page":"e746","DOI":"10.1161\/STROKEAHA.121.036141","article-title":"Keeping up with the medical literature: Why, how, and when?","volume":"52","author":"Kamtchum-Tatuene","year":"2021","journal-title":"Stroke"},{"key":"R6-20241003","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2146\/ajhp130303","article-title":"Major publications in the critical care pharmacotherapy literature: February 2012 through February 2013.","volume":"71","author":"Turck","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"R7-20241003","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2146\/ajhp140241","article-title":"Major publications in the critical care pharmacotherapy literature: January-December 2013.","volume":"72","author":"Rech","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"R8-20241003","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.2146\/ajhp150220","article-title":"Major publications in the critical care pharmacotherapy literature: January-December 2014.","volume":"72","author":"Day","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"R9-20241003","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2146\/ajhp160144","article-title":"Major publications in the critical care pharmacotherapy literature in 2015.","volume":"74","author":"Wong","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"R10-20241003","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jcrc.2017.09.178","article-title":"Major publications in the critical care pharmacotherapy literature: January-December 2016.","volume":"43","author":"Horner","year":"2018","journal-title":"J Crit Care"},{"key":"R11-20241003","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcrc.2018.02.012","article-title":"Major publications in the critical care pharmacotherapy literature: January-December 2017.","volume":"45","author":"Hammond","year":"2018","journal-title":"J Crit Care"},{"key":"R12-20241003","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jcrc.2019.04.029","article-title":"Major publications in the critical care pharmacotherapy literature in 2018.","volume":"52","author":"Sikora Newsome","year":"2019","journal-title":"J Crit Care"},{"key":"R13-20241003","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jcrc.2020.12.018","article-title":"Major publications in the critical care pharmacotherapy literature: 2019.","volume":"62","author":"Smith Condeni","year":"2021","journal-title":"J Crit Care"},{"key":"R14-20241003","doi-asserted-by":"crossref","first-page":"e0590","DOI":"10.1097\/CCE.0000000000000590","article-title":"Major publications in the critical care pharmacotherapy literature: 2020.","volume":"3","author":"Bissell","year":"2021","journal-title":"Crit Care Explor"},{"key":"R15-20241003","doi-asserted-by":"crossref","first-page":"e0823","DOI":"10.1097\/CCE.0000000000000823","article-title":"Major publications in the critical care pharmacotherapy literature: 2021.","volume":"4","author":"Wieruszewski","year":"2022","journal-title":"Crit Care Explor"},{"key":"R16-20241003","doi-asserted-by":"crossref","first-page":"e0981","DOI":"10.1097\/CCE.0000000000000981","article-title":"Major publications in the critical care pharmacotherapy literature: 2022.","volume":"5","author":"Gurnani","year":"2023","journal-title":"Crit Care Explor"},{"key":"R17-20241003","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia.","volume":"388","author":"Dequin","year":"2023","journal-title":"N Engl J Med"},{"key":"R18-20241003","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial.","volume":"313","author":"Torres","year":"2015","journal-title":"JAMA"},{"key":"R19-20241003","doi-asserted-by":"crossref","first-page":"107663","DOI":"10.1016\/j.pharmthera.2020.107663","article-title":"Updates on community acquired pneumonia management in the ICU.","volume":"217","author":"Nair","year":"2021","journal-title":"Pharmacol Ther"},{"key":"R20-20241003","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/cix801","article-title":"Corticosteroids in patients hospitalized with community-acquired pneumonia: Systematic review and individual patient data metaanalysis.","volume":"66","author":"Briel","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R21-20241003","first-page":"CD007720","article-title":"Corticosteroids for pneumonia.","volume":"12","author":"Stern","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R22-20241003","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","article-title":"2024 focused update: Guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia.","volume":"52","author":"Chaudhuri","year":"2024","journal-title":"Crit Care Med"},{"key":"R23-20241003","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care-associated infections in US hospitals.","volume":"379","author":"Magill","year":"2018","journal-title":"N Engl J Med"},{"key":"R24-20241003","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMsa1300991","article-title":"National trends in patient safety for four common conditions, 2005-2011.","volume":"370","author":"Wang","year":"2014","journal-title":"N Engl J Med"},{"key":"R25-20241003","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society.","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R26-20241003","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01704698","article-title":"Prevention of gram negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients. Histologic and bacteriologic study.","volume":"20","author":"Rouby","year":"1994","journal-title":"Intensive Care Med"},{"key":"R27-20241003","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1592\/phco.22.12.972.33596","article-title":"Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients.","volume":"22","author":"Wood","year":"2002","journal-title":"Pharmacotherapy"},{"key":"R28-20241003","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/sur.2006.042","article-title":"Aerosolized ceftazidime prophylaxis against ventilator-associated pneumonia in high-risk trauma patients: Results of a double-blind randomized study.","volume":"8","author":"Claridge","year":"2007","journal-title":"Surg Infect (Larchmt)"},{"key":"R29-20241003","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1183\/13993003.02235-2014","article-title":"Nebulised colistin for ventilator-associated pneumonia prevention.","volume":"46","author":"Karvouniaris","year":"2015","journal-title":"Eur Respir J"},{"key":"R30-20241003","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1007\/BF01752973","article-title":"Systemic and endotracheal antibiotic prophylaxis of nosocomial pneumonia in ICU.","volume":"18","author":"Lode","year":"1992","journal-title":"Intensive Care Med"},{"key":"R31-20241003","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1017\/ice.2022.88","article-title":"Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update.","volume":"43","author":"Klompas","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R32-20241003","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJMoa2212663","article-title":"Early restrictive or liberal fluid management for sepsis-induced hypotension.","volume":"388","author":"Shapiro","year":"2023","journal-title":"N Engl J Med"},{"key":"R33-20241003","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.2017.13836","article-title":"Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014.","volume":"318","author":"Rhee","year":"2017","journal-title":"JAMA"},{"key":"R34-20241003","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","article-title":"Incidence and mortality of hospital- and ICU-treated sepsis: Results from an updated and expanded systematic review and meta-analysis.","volume":"46","author":"Fleischmann-Struzek","year":"2020","journal-title":"Intensive Care Med"},{"key":"R35-20241003","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock.","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"R36-20241003","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021.","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"R37-20241003","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/SHK.0000000000000268","article-title":"Fluid overload in patients with severe sepsis and septic shock treated with early goal-directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death.","volume":"43","author":"Kelm","year":"2015","journal-title":"Shock"},{"key":"R38-20241003","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jama.2019.0071","article-title":"Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: The ANDROMEDA-SHOCK randomized clinical trial.","volume":"321","author":"Hernandez","year":"2019","journal-title":"JAMA"},{"key":"R39-20241003","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1056\/NEJMoa2202707","article-title":"Restriction of intravenous fluid in ICU patients with septic shock.","volume":"386","author":"Meyhoff","year":"2022","journal-title":"N Engl J Med"},{"key":"R40-20241003","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13054-023-04397-7","article-title":"Early adjunctive methylene blue in patients with septic shock: A randomized controlled trial.","volume":"27","author":"Ibarra-Estrada","year":"2023","journal-title":"Crit Care"},{"key":"R41-20241003","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock.","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"R42-20241003","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock.","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"R43-20241003","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/CCM.0000000000005317","article-title":"Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock.","volume":"50","author":"Sacha","year":"2022","journal-title":"Crit Care Med"},{"key":"R44-20241003","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/phar.2105","article-title":"Prospective open-label trial of early concomitant vasopressin and norepinephrine therapy versus initial norepinephrine monotherapy in septic shock.","volume":"38","author":"Hammond","year":"2018","journal-title":"Pharmacotherapy"},{"key":"R45-20241003","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/10600280211021103","article-title":"Comparison of early versus late initiation of hydrocortisone in patients with septic shock in the ICU setting.","volume":"56","author":"Ragoonanan","year":"2022","journal-title":"Ann Pharmacother"},{"key":"R46-20241003","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.CCM.0000105581.01815.C6","article-title":"Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock.","volume":"32","author":"Lopez","year":"2004","journal-title":"Crit Care Med"},{"key":"R47-20241003","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/0310057X0203000606","article-title":"The influence of methylene blue infusion on cytokine levels during severe sepsis.","volume":"30","author":"Memis","year":"2022","journal-title":"Anaesth Intensive Care"},{"key":"R48-20241003","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","article-title":"Infusion of methylene blue in human septic shock: A pilot, randomized, controlled study.","volume":"29","author":"Kirov","year":"2001","journal-title":"Crit Care Med"},{"key":"R49-20241003","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2023.4080","article-title":"Efficacy and safety of early administration of 4-factor prothrombin complex concentrate in patients with trauma at risk of massive transfusion: The PROCOAG randomized clinical trial.","volume":"329","author":"Bouzat","year":"2023","journal-title":"JAMA"},{"key":"R50-20241003","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/archsurg.1997.01430300062013","article-title":"Blood transfusion. An independent risk factor for postinjury multiple organ failure.","volume":"132","author":"Moore","year":"1997","journal-title":"Arch Surg"},{"key":"R51-20241003","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/TA.0000000000002262","article-title":"Four-factor prothrombin complex concentrate is associated with improved survival in trauma-related hemorrhage: A nationwide propensity-matched analysis.","volume":"87","author":"Zeeshan","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"key":"R52-20241003","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/TA.0000000000001938","article-title":"The role of four-factor prothrombin complex concentrate in coagulopathy of trauma: A propensity matched analysis.","volume":"85","author":"Jehan","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"key":"R53-20241003","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-023-04688-z","article-title":"Prothrombin complex concentrate (PCC) for treatment of trauma-induced coagulopathy: Systematic review and meta-analyses.","volume":"27","author":"Hannadjas","year":"2023","journal-title":"Crit Care"},{"key":"R54-20241003","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/TA.0000000000001333","article-title":"Damage control resuscitation in patients with severe traumatic hemorrhage: A practice management guideline from the Eastern Association for the Surgery of Trauma.","volume":"82","author":"Cannon","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"R55-20241003","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13054-023-04327-7","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: Sixth edition.","volume":"27","author":"Rossaint","year":"2023","journal-title":"Crit Care"},{"key":"R56-20241003","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/CIRCULATIONAHA.121.057844","article-title":"Final study report of andexanet alfa for major bleeding with factor Xa inhibitors.","volume":"147","author":"Milling","year":"2023","journal-title":"Circulation"},{"key":"R57-20241003","first-page":"279","article-title":"Andexanet alfa for acute major bleeding associated with factor Xa inhibitors.","volume":"65","author":"Connolly","year":"2016","journal-title":"N Engl J Med"},{"key":"R58-20241003","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors.","volume":"380","author":"Connolly","year":"2019","journal-title":"N Engl J Med"},{"key":"R59-20241003","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJMoa2313040","article-title":"Andexanet for factor Xa inhibitor-associated acute intracerebral hemorrhage.","volume":"390","author":"Connolly","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T13:01:07Z","timestamp":1727960467000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":59,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001162","relation":{},"ISSN":["2639-8028"],"issn-type":[{"type":"electronic","value":"2639-8028"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}